Tirzepatide, a drug approved for diabetes and on the fast track for approval as a weight reduction therapy, works through a novel ability to activate two different mechanisms the body uses to manage insulin secretion and energy balance, Duke Health researchers report. The finding, reported June 5 within the journal Nature Metabolism, is the primary […]